{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:01:00Z","timestamp":1790834460279,"version":"4.1.0"},"reference-count":262,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero Dell\u2019Istruzione, dell\u2019Universit\u00e0 e Della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Despite extensive research, brain tumors still have some of the lowest survival rates among cancers. Their marked resistance to both conventional and emerging therapies stems from the unique properties of neural cells and their microenvironment, including the blood-brain barrier, cellular heterogeneity, and an immunosuppressive milieu. Addressing these challenges is essential for developing effective therapeutic strategies that improve patient outcomes. Advancements in brain tumor treatment depend on understanding the biological mechanisms behind potential drug targets and developing appropriate drug discovery strategies to inhibit them effectively. A major barrier remains the difficulty many drugs face in crossing the blood-brain barrier, which greatly restrains treatment effectiveness in brain tumor patients. Therefore, developing innovative drug delivery systems is essential. The brain exhibits a high concentration of fatty acids, notably polyunsaturated fatty acids such as arachidonic acid (AA), which are primarily esterified within membrane phospholipids. Upon release, cyclooxygenases, lipoxygenases, and cytochrome P450 enzymes can transform AA into various eicosanoid classes, producing lipid mediators involved in signal transduction pathways that regulate neurotransmission, neuroinflammation, and neuroplasticity. The diverse eicosanoid families can be synthesized within brain tumors and may contribute to tumor heterogeneity. This includes cell-specific eicosanoid production involving cancer cells, microglia, infiltrating immune cells, and platelets, each expressing distinct enzymes that facilitate tumor progression and immune evasion. This review examines the various mechanisms underlying brain cancer biology, with a particular focus on the roles of eicosanoids and their signaling pathways and how they affect tumor development, progression, and resistance to therapies. The review also describes therapeutic strategies targeting these pathways. The challenge of reduced responsiveness to therapeutic interventions is addressed through platelet-based drug delivery systems, which can increase efficacy by transporting chemotherapeutic agents directly to cancer cells. These systems also include nanoparticles coated with platelet membranes to evade immune clearance of intact cells and extracellular vesicles that provide high biocompatibility. Finally, tumor-educated platelets\u2014which carry RNA and protein cargo\u2014are presented as noninvasive biomarkers for diagnosing and monitoring disease progression and response to therapies in brain tumors.<\/jats:p>","DOI":"10.3389\/fphar.2026.1956969","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:41:19Z","timestamp":1790833279000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The future of brain tumor treatment: integrating platelet-based liquid biopsy, advanced drug delivery systems, and eicosanoid inhibition"],"prefix":"10.3389","volume":"17","author":[{"given":"Sara","family":"Di Berardino","sequence":"first","affiliation":[{"name":"Systems Pharmacology and Translational Therapeutics Laboratory, at the Center for Advanced Studies and Technology (CAST), and Department of Neuroscience, Imaging and Clinical Science, \u201cG. d'Annunzio\u201d University","place":["Chieti, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Zar\u00e0","sequence":"additional","affiliation":[{"name":"Department of Biology and Biotechnology, University of Pavia","place":["Pavia, Italy"]},{"name":"IRCCS Policlinico San Matteo Foundation","place":["Pavia, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huzaifa Ali","family":"Ahfaz","sequence":"additional","affiliation":[{"name":"Systems Pharmacology and Translational Therapeutics Laboratory, at the Center for Advanced Studies and Technology (CAST), and Department of Neuroscience, Imaging and Clinical Science, \u201cG. d'Annunzio\u201d University","place":["Chieti, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Tacconelli","sequence":"additional","affiliation":[{"name":"Systems Pharmacology and Translational Therapeutics Laboratory, at the Center for Advanced Studies and Technology (CAST), and Department of Neuroscience, Imaging and Clinical Science, \u201cG. d'Annunzio\u201d University","place":["Chieti, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Patrignani","sequence":"additional","affiliation":[{"name":"Systems Pharmacology and Translational Therapeutics Laboratory, at the Center for Advanced Studies and Technology (CAST), and Department of Neuroscience, Imaging and Clinical Science, \u201cG. d'Annunzio\u201d University","place":["Chieti, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1161\/ATVBAHA.118.311407","article-title":"Transfusion of platelets loaded with recombinant ADAMTS13 (A disintegrin and metalloprotease with thrombospondin type 1 Repeats-13) is efficacious for inhibiting arterial thrombosis associated with thrombotic thrombocytopenic purpura","volume":"38","author":"Abdelgawwad","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1165\/ajrcmb\/8.3.273","article-title":"Human tracheal epithelial cells selectively incorporate 15-Hydroxyeicosatetraenoic acid into phosphatidylinositol","volume":"8","author":"Alpert","year":"1993","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1158\/1055-9965.EPI-18-0702","article-title":"Aspirin, NSAIDs, and glioma risk: original data from the glioma international case\u2013control study and a meta-analysis","volume":"28","author":"Amirian","year":"2019","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood\u2013brain barrier and blood\u2013tumour barrier in brain tumours and metastases","volume":"20","author":"Arvanitis","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1038\/s41467-021-22311-z","article-title":"Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors","volume":"12","author":"Bahmani","year":"2021","journal-title":"Nat. Commun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1161\/ATVBAHA.120.314180","article-title":"Platelets endocytose viral particles and are activated via TLR (Toll-Like receptor) signaling","volume":"40","author":"Banerjee","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrn3820","article-title":"Polyunsaturated fatty acids and their metabolites in brain function and disease","volume":"15","author":"Bazinet","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1038\/s41467-022-29606-9","article-title":"Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations","volume":"13","author":"Bell","year":"2022","journal-title":"Nat. Commun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/FJC.0b013e318273b007","article-title":"Epoxyeicosatrienoic acid pathway in human health and diseases","volume":"61","author":"Bellien","year":"2013","journal-title":"J. Cardiovasc Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in Early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.drudis.2018.02.001","article-title":"Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics","volume":"23","author":"Bose","year":"2018","journal-title":"Drug Discov. Today"},{"key":"B12","doi-asserted-by":"publisher","first-page":"6840","DOI":"10.18632\/oncotarget.3160","article-title":"Radiation-induced PGE2 sustains human glioma cell growth and survival through EGF signaling","volume":"6","author":"Brocard","year":"2015","journal-title":"Oncotarget"},{"key":"B13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1215\/15228517-2007-013","article-title":"Preoperative thrombocytosis predicts poor survival in patients with glioblastoma","volume":"9","author":"Brockmann","year":"2007","journal-title":"Neuro-Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11060-011-0560-2","article-title":"Differential effects of tumor\u2013platelet interaction in vitro and in vivo in glioblastoma","volume":"105","author":"Brockmann","year":"2011","journal-title":"J. Neurooncol"},{"key":"B15","first-page":"59","article-title":"Inducible cyclooxygenase (COX-2) in glioblastoma--clinical and immunohistochemical (COX-2-VEGF) correlations","volume":"25","author":"Buccoliero","year":"2006","journal-title":"Clin. Neuropathol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0021-9258(20)78929-5","article-title":"On the nature and r\u00f4le of the fatty acids essential in nutrition","volume":"86","author":"Burr","year":"1930","journal-title":"J. Biol. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1080\/17425247.2023.2217378","article-title":"Platelets for advanced drug delivery in cancer","volume":"20","author":"Cacic","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"B18","doi-asserted-by":"publisher","first-page":"592S","DOI":"10.3945\/jn.111.155259","article-title":"Mechanisms of action of (n-3) fatty acids","volume":"142","author":"Calder","year":"2012","journal-title":"J. Nutr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"158573","DOI":"10.1016\/j.bbalip.2019.158573","article-title":"GPR75 receptor mediates 20-HETE-signaling and metastatic features of androgen-insensitive prostate cancer cells","volume":"1865","author":"C\u00e1rdenas","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"B20","doi-asserted-by":"publisher","first-page":"111784","DOI":"10.1016\/j.mce.2022.111784","article-title":"20-HETE\/GPR75 pairing modulates the expression and transcriptional activity of the androgen receptor in androgen-sensitive prostate cancer cells","volume":"559","author":"C\u00e1rdenas","year":"2023","journal-title":"Mol. Cell Endocrinol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.3390\/ijms22063019","article-title":"In ovarian cancer multicellular spheroids, platelet releasate promotes growth, expansion of ALDH+ and CD133+ cancer stem cells, and protection against the cytotoxic effects of cisplatin, carboplatin and paclitaxel","volume":"22","author":"Casagrande","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev.med.57.121304.131253","article-title":"NSAIDs and cancer prevention: targets downstream of COX-2","volume":"58","author":"Cha","year":"2007","journal-title":"Annu. Rev. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"13590","DOI":"10.1002\/anie.201506500","article-title":"Controlled transcription of exogenous mRNA in platelets using protocells","volume":"54","author":"Chan","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"B24","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/cbin.10067","article-title":"Direct TGF\u2010\u03b21 signaling between activated platelets and pancreatic cancer cells primes cisplatin insensitivity","volume":"37","author":"Chen","year":"2013","journal-title":"Cell Biol. Int."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1039\/C9BM00599D","article-title":"Platelet-membrane-camouflaged bismuth sulfide nanorods for synergistic radio-photothermal therapy against cancer","volume":"7","author":"Chen","year":"2019","journal-title":"Biomater. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"188957","DOI":"10.1016\/j.bbcan.2023.188957","article-title":"The complex role of eicosanoids in the brain: implications for brain tumor development and therapeutic opportunities","volume":"1878","author":"Chen","year":"2023","journal-title":"Biochim. Biophys. Acta BBA - Rev. Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1121401","DOI":"10.3389\/fonc.2023.1121401","article-title":"Platelets in the tumor microenvironment and their biological effects on cancer hallmarks","volume":"13","author":"Chen","year":"2023","journal-title":"Front. Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e009492","DOI":"10.1136\/jitc-2024-009492","article-title":"ALOX5 contributes to glioma progression by promoting 5-HETE-mediated immunosuppressive M2 polarization and PD-L1 expression of glioma-associated microglia\/macrophages","volume":"12","author":"Chen","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"100255","DOI":"10.1016\/j.jnrt.2025.100255","article-title":"CXCL14\u2013CXCR4-mediated platelet migration across the blood\u2013brain barrier and subsequent microglia and astrocyte activation in arterial baroreflex dysfunction","volume":"14","author":"Chen","year":"2026","journal-title":"J. Neurorestoratology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.nbd.2009.09.015","article-title":"Contribution of reactive oxygen species to migration\/invasion of human glioblastoma cells U87 via ERK-dependent COX-2\/PGE(2) activation","volume":"37","author":"Chiu","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s13770-021-00361-0","article-title":"Biodistribution of exosomes and engineering strategies for targeted delivery of therapeutic exosomes","volume":"18","author":"Choi","year":"2021","journal-title":"Tissue Eng. Regen. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1158\/1535-7163.MCT-06-0318","article-title":"Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells","volume":"5","author":"Cianchi","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.prostaglandins.2012.07.004","article-title":"12- and 15-lipoxygenases in adipose tissue inflammation","volume":"104","author":"Cole","year":"2013","journal-title":"Prostagl. Other Lipid Mediat"},{"key":"B34","doi-asserted-by":"publisher","first-page":"100109","DOI":"10.1016\/j.jlr.2021.100109","article-title":"Platelets induce free and phospholipid-esterified 12-hydroxyeicosatetraenoic acid generation in colon cancer cells by delivering 12-lipoxygenase","volume":"62","author":"Contursi","year":"2021","journal-title":"J. Lipid Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"115252","DOI":"10.1016\/j.bcp.2022.115252","article-title":"Biology and pharmacology of platelet-type 12-lipoxygenase in platelets, cancer cells, and their crosstalk","volume":"205","author":"Contursi","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.294.1.47","article-title":"Low-dose aspirin in the primary prevention of cancer: the Women\u2019s health study: a randomized controlled trial","volume":"294","author":"Cook","year":"2005","journal-title":"JAMA"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/neuonc\/now049","article-title":"Cox-2-derived PGE2 induces Id1-dependent radiation resistance and self-renewal in experimental glioblastoma","volume":"18","author":"Cook","year":"2016","journal-title":"Neuro-Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.ejca.2011.12.013","article-title":"Epidemiology of glial and non-glial brain tumours in Europe","volume":"48","author":"Crocetti","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.3390\/cancers15082336","article-title":"Platelet-based liquid biopsies through the lens of machine learning","volume":"15","author":"Cygert","year":"2023","journal-title":"Cancers"},{"key":"B40","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/s1535-6108(03)00310-6","article-title":"Targeting cyclooxygenase-2 in human neoplasia: rationale and promise","volume":"4","author":"Dannenberg","year":"2003","journal-title":"Cancer Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1116014","DOI":"10.3389\/fonc.2022.1116014","article-title":"Pleiotropic effects of the COX-2\/PGE2 axis in the glioblastoma tumor microenvironment","volume":"12","author":"Dean","year":"2023","journal-title":"Front. Oncol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/s0165-5728(98)00257-4","article-title":"Cyclooxygenases-1 and -2 are differentially localized to microglia and endothelium in rat EAE and glioma","volume":"95","author":"Deininger","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"noag155","DOI":"10.1093\/neuonc\/noag155","article-title":"FUS-Mediated BBB opening reshapes plasma extracellular vesicle size distribution without elevating concentration in glioblastoma patients","author":"Del Bene","year":"2026","journal-title":"Neuro-Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4081\/btvb.2026.443","article-title":"Platelet-derived thromboxane A2 induces cyclooxygenase-2 and epithelial-mesenchymal transition marker genes in U-87MG human glioblastoma cells","volume":"5","author":"Di","year":"2026","journal-title":"Bleeding Thromb. Vasc. Biol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.2147\/IJN.S403339","article-title":"Doxorubicin-loaded platelet decoys for enhanced chemoimmunotherapy against triple-negative breast cancer in mice model","volume":"18","author":"Dong","year":"2023","journal-title":"Int. J. Nanomedicine"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1093\/neuonc\/not122","article-title":"Time trends in glioblastoma multiforme survival: the role of temozolomide","volume":"15","author":"Dubrow","year":"2013","journal-title":"Neuro-Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/pharmaceutics9010009","article-title":"Clinical implications of 20-Hydroxyeicosatetraenoic acid in the kidney, liver, lung and brain: an emerging therapeutic target","volume":"9","author":"Elshenawy","year":"2017","journal-title":"Pharmaceutics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1440-1746.2004.03194.x","article-title":"Five-lipoxygenase-activating protein inhibitor MK-886 induces apoptosis in gastric cancer through upregulation of p27kip1 and bax","volume":"19","author":"Fan","year":"2004","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.actbio.2022.10.031","article-title":"Surface-anchored tumor microenvironment-responsive protein nanogel-platelet system for cytosolic delivery of therapeutic protein in the post-surgical cancer treatment","volume":"154","author":"Fan","year":"2022","journal-title":"Acta Biomater."},{"key":"B50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"18061","DOI":"10.1038\/s41598-020-73005-3","article-title":"Mode of induction of platelet-derived extracellular vesicles is a critical determinant of their phenotype and function","volume":"10","author":"Ferreira","year":"2020","journal-title":"Sci. Rep."},{"key":"B52","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3390\/biology9120434","article-title":"Prostaglandin E2 and cancer: insight into tumor progression and immunity","volume":"9","author":"Finetti","year":"2020","journal-title":"Biology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1056\/NEJMp048288","article-title":"Coxibs and cardiovascular disease","volume":"351","author":"FitzGerald","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1056\/NEJM200108093450607","article-title":"The coxibs, selective inhibitors of Cyclooxygenase-2","volume":"345","author":"FitzGerald","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1158\/2767-9764.CRC-23-0249","article-title":"Dual blockade of EP2 and EP4 signaling is required for optimal immune activation and antitumor activity against prostaglandin-expressing tumors","volume":"3","author":"Francica","year":"2023","journal-title":"Cancer Res. Commun."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.cell.2017.11.001","article-title":"Migrating platelets are mechano-scavengers that collect and bundle bacteria","volume":"171","author":"Gaertner","year":"2017","journal-title":"Cell"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1002\/cncr.27817","article-title":"Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: the Women\u2019s health initiative","volume":"119","author":"Gamba","year":"2013","journal-title":"Cancer"},{"key":"B58","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1182\/bloodadvances.2020001658","article-title":"Processing methods and storage duration impact extracellular vesicle counts in red blood cell units","volume":"4","author":"Gamonet","year":"2020","journal-title":"Blood Adv."},{"key":"B59","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1021\/acsabm.2c00869","article-title":"Engineering platelets with PDL1 antibodies and iron oxide nanoparticles for postsurgical cancer immunotherapy","volume":"6","author":"Gao","year":"2023","journal-title":"ACS Appl. Bio Mater"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1161\/CIRCRESAHA.116.310525","article-title":"20-HETE signals through G-Protein-Coupled receptor GPR75 (Gq) to affect vascular function and trigger hypertension","volume":"120","author":"Garcia","year":"2017","journal-title":"Circ. Res."},{"key":"B61","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-3-642-30331-9_4","article-title":"Coxibs: pharmacology, toxicity and efficacy in cancer clinical trials","volume-title":"Prospects for Chemoprevention of Colorectal Neoplasia","author":"Garcia Rodriguez","year":"2013"},{"key":"B62","doi-asserted-by":"publisher","first-page":"R38","DOI":"10.1186\/bcr2089","article-title":"Nonsteroidal anti-inflammatory drugs and breast cancer risk in the national institutes of Health-AARP diet and health study","volume":"10","author":"Gierach","year":"2008","journal-title":"Breast Cancer Res. BCR"},{"key":"B63","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/978-1-4419-9194-2_44","article-title":"Increased expression of 5-lipoxygenase in glioblastoma multiforme","volume":"525","author":"Golubic","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.prostaglandins.2009.05.002","article-title":"5-Oxo-ETE and the OXE receptor","volume":"89","author":"Grant","year":"2009","journal-title":"Prostagl. Other Lipid Mediat"},{"key":"B65","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1172\/JCI27291","article-title":"Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities","volume":"116","author":"Grosser","year":"2005","journal-title":"J. Clin. Invest"},{"key":"B66","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1124\/jpet.108.140889","article-title":"Expression of CYP4A1 in U251 human glioma cell induces hyperproliferative phenotype in vitro and rapidly growing tumors in vivo","volume":"327","author":"Guo","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B67","doi-asserted-by":"publisher","first-page":"33832","DOI":"10.1074\/jbc.M110.216564","article-title":"Identification of the orphan G Protein-coupled receptor GPR31 as a receptor for 12-(S)-Hydroxyeicosatetraenoic acid","volume":"286","author":"Guo","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00280-011-1595-y","article-title":"Role of 12-lipoxygenase in regulation of ovarian cancer cell proliferation and survival","volume":"68","author":"Guo","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.bioactmat.2022.02.013","article-title":"Eliminating the original cargos of glioblastoma cell-derived small extracellular vesicles for efficient drug delivery to glioblastoma with improved biosafety","volume":"16","author":"Guo","year":"2022","journal-title":"Bioact. Mater"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1172\/JCI97945","article-title":"Leukotriene biosynthetic enzymes as therapeutic targets","volume":"128","author":"Haeggstr\u00f6m","year":"2018","journal-title":"J. Clin. Invest"},{"key":"B71","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ccell.2018.03.002","article-title":"The platelet lifeline to cancer: challenges and opportunities","volume":"33","author":"Haemmerle","year":"2018","journal-title":"Cancer Cell"},{"key":"B72","doi-asserted-by":"publisher","first-page":"591819","DOI":"10.3389\/fendo.2020.591819","article-title":"The biosynthesis of enzymatically oxidized lipids","volume":"11","author":"Hajeyah","year":"2020","journal-title":"Front. Endocrinol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1021\/acsnano.7b00929","article-title":"Platelet\u2013microcapsule hybrids leverage contractile force for targeted delivery of hemostatic agents","volume":"11","author":"Hansen","year":"2017","journal-title":"ACS Nano"},{"key":"B74","doi-asserted-by":"publisher","first-page":"42929","DOI":"10.1074\/jbc.M403013200","article-title":"Crystal structure of arachidonic acid bound to a mutant of prostaglandin endoperoxide H Synthase-1 that forms predominantly 11-Hydroperoxyeicosatetraenoic acid","volume":"279","author":"Harman","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B75","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1038\/sj.onc.1210113","article-title":"Prostaglandin E2-EP4 receptor signalling promotes tumorigenic behaviour of HT-29 human colorectal cancer cells","volume":"26","author":"Hawcroft","year":"2007","journal-title":"Oncogene"},{"key":"B76","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3389\/fphar.2020.00533","article-title":"Cyclooxygenase 2-Regulated genes an alternative avenue to the development of new therapeutic drugs for colorectal cancer","volume":"11","author":"Hidalgo-Est\u00e9vez","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00262-011-1064-9","article-title":"Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4","volume":"60","author":"Holt","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"B78","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.1002\/adma.201503323","article-title":"Anticancer platelet\u2010mimicking nanovehicles","volume":"27","author":"Hu","year":"2015","journal-title":"Adv. Mater"},{"key":"B79","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s41551-018-0310-2","article-title":"Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy","volume":"2","author":"Hu","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/s41551-021-00712-1","article-title":"Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets","volume":"5","author":"Hu","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.06.015","article-title":"Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics","volume":"192","author":"Imig","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"B82","doi-asserted-by":"publisher","first-page":"445","DOI":"10.5414\/NPP28445","article-title":"5-lipoxygenase pathway promotes cell proliferation in human glioma cell lines","volume":"28","author":"Ishii","year":"2009","journal-title":"Clin. Neuropathol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2015.07.073","article-title":"Structural and functional biology of arachidonic acid 15-lipoxygenase-1 (ALOX15)","volume":"573","author":"Ivanov","year":"2015","journal-title":"Gene"},{"key":"B84","doi-asserted-by":"publisher","first-page":"6665","DOI":"10.1158\/0008-5472.CAN-06-3643","article-title":"Cytochrome P 450 epoxygenase promotes human cancer metastasis","volume":"67","author":"Jiang","year":"2007","journal-title":"Cancer Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.trecan.2016.12.002","article-title":"Prostaglandin E2 signaling: alternative target for glioblastoma?","volume":"3","author":"Jiang","year":"2017","journal-title":"Trends Cancer"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2001704","DOI":"10.1002\/smll.202001704","article-title":"Platelet membrane\u2010camouflaged magnetic nanoparticles for ferroptosis\u2010enhanced cancer immunotherapy","volume":"16","author":"Jiang","year":"2020","journal-title":"Small"},{"key":"B87","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s12032-013-0718-1","article-title":"Association of polymorphisms in FLT3, EGFR, ALOX5, and NEIL3 with glioblastoma in the han Chinese population","volume":"30","author":"Jin","year":"2013","journal-title":"Med. Oncol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.7150\/thno.23654","article-title":"Platelet-camouflaged nanococktail: simultaneous inhibition of drug-resistant tumor growth and metastasis via a cancer cells and tumor vasculature dual-targeting strategy","volume":"8","author":"Jing","year":"2018","journal-title":"Theranostics"},{"key":"B89","doi-asserted-by":"publisher","first-page":"12332","DOI":"10.1002\/jev2.12332","article-title":"First\u2010in\u2010human clinical trial of allogeneic, platelet\u2010derived extracellular vesicles as a potential therapeutic for delayed wound healing","volume":"12","author":"Johnson","year":"2023","journal-title":"J. Extracell. Vesicles"},{"key":"B90","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/ni943","article-title":"Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity","volume":"4","author":"Kabashima","year":"2003","journal-title":"Nat. Immunol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.18632\/oncotarget.27223","article-title":"Engineered human platelet-derived microparticles as natural vectors for targeted drug delivery","volume":"10","author":"Kailashiya","year":"2019","journal-title":"Oncotarget"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e12085","DOI":"10.1002\/jev2.12085","article-title":"Biodistribution of extracellular vesicles following administration into animals: a systematic review","volume":"10","author":"Kang","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"B93","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12944-023-01881-5","article-title":"Dysregulated lipid metabolism in TMZ-resistant glioblastoma: pathways, proteins, metabolites and therapeutic opportunities","volume":"22","author":"Kao","year":"2023","journal-title":"Lipids Health Dis."},{"key":"B94","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1073\/pnas.93.6.2317","article-title":"COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex","volume":"93","author":"Kaufmann","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.ultrasmedbio.2025.04.019","article-title":"Response of serum-isolated extracellular vesicles to focused ultrasound-mediated blood-brain barrier opening","volume":"51","author":"Kline-Schoder","year":"2025","journal-title":"Ultrasound Med. Biol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3390\/cancers15030946","article-title":"Synthesis and significance of arachidonic acid, a substrate for cyclooxygenases, lipoxygenases, and cytochrome P450 pathways in the tumorigenesis of glioblastoma multiforme, including a pan-cancer comparative analysis","volume":"15","author":"Korbecki","year":"2023","journal-title":"Cancers"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2015.06.022","article-title":"Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders","volume":"98","author":"Koeberle","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/00041433-200206000-00007","article-title":"Cytochrome P450 pathways of arachidonic acid metabolism","volume":"13","author":"Kroetz","year":"2002","journal-title":"Curr. Opin. Lipidol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.bbalip.2014.10.002","article-title":"Mammalian lipoxygenases and their biological relevance","volume":"1851","author":"Kuhn","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"B100","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.bbalip.2017.04.001","article-title":"Mammalian ALOX15 orthologs exhibit pronounced dual positional specificity with docosahexaenoic acid","volume":"1862","author":"Kutzner","year":"2017","journal-title":"Biochim. Biophys. Acta BBA - Mol. Cell Biol. Lipids"},{"key":"B101","doi-asserted-by":"publisher","first-page":"E3053","DOI":"10.1073\/pnas.1411082111","article-title":"Platelets guide the formation of early metastatic niches","volume":"111","author":"Labelle","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B102","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1046\/j.1471-4159.1996.66010147.x","article-title":"Arachidonate 5\u2010Lipoxygenase and its activating protein: prominent hippocampal expression and role in somatostatin signaling","volume":"66","author":"Lammers","year":"1996","journal-title":"J. Neurochem."},{"key":"B103","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.prostaglandins.2015.06.002","article-title":"Inhibition of microsomal prostaglandin E synthase-1 as targeted therapy in cancer treatment","volume":"120","author":"Larsson","year":"2015","journal-title":"Prostagl. Other Lipid Mediat"},{"key":"B104","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1161\/ATVBAHA.113.301335","article-title":"15-Lipoxygenase promotes chronic hypoxia\u2013induced pulmonary artery inflammation via positive interaction with nuclear Factor-\u03baB","volume":"33","author":"Li","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"25077","DOI":"10.1038\/srep25077","article-title":"Platelet-cytokine complex suppresses tumour growth by exploiting intratumoural thrombin-dependent platelet aggregation","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"B106","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jconrel.2016.02.036","article-title":"Genetic engineering of platelets to neutralize circulating tumor cells","volume":"228","author":"Li","year":"2016","journal-title":"J. Control. Release"},{"key":"B107","doi-asserted-by":"publisher","first-page":"87353","DOI":"10.18632\/oncotarget.20928","article-title":"COX-2\/sEH dual inhibitor PTUPB suppresses glioblastoma growth by targeting epidermal growth factor receptor and hyaluronan mediated motility receptor","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"B108","doi-asserted-by":"publisher","first-page":"110389","DOI":"10.1016\/j.biopha.2020.110389","article-title":"Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: recent advancement","volume":"129","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"B109","doi-asserted-by":"publisher","first-page":"113893","DOI":"10.1016\/j.celrep.2024.113893","article-title":"Structural basis for ligand recognition and activation of the prostanoid receptors","volume":"43","author":"Li","year":"2024","journal-title":"Cell Rep."},{"key":"B110","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11060-009-0036-9","article-title":"MK886-induced apoptosis depends on the 5-LO expression level in human malignant glioma cells","volume":"97","author":"Lim","year":"2010","journal-title":"J. Neurooncol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","article-title":"Current state of immunotherapy for glioblastoma","volume":"15","author":"Lim","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3390\/cells8101182","article-title":"Zileuton, a 5-Lipoxygenase inhibitor, exerts anti-angiogenic effect by inducing apoptosis of HUVEC via BK channel activation","volume":"8","author":"Lim","year":"2019","journal-title":"Cells"},{"key":"B113","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3389\/fphar.2019.00836","article-title":"The role of prostaglandin-endoperoxide Synthase-2 in chemoresistance of non-small cell lung cancer","volume":"10","author":"Lin","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1023\/A:1015782809966","article-title":"The alteration of prostaglandin E2 levels in patients with brain tumors before and after tumor removal","volume":"57","author":"Loh","year":"2002","journal-title":"J. Neurooncol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3390\/ijms23031545","article-title":"Up-Regulation of Cyclooxygenase-2 (COX-2) expression by temozolomide (TMZ) in human glioblastoma (GBM) cell lines","volume":"23","author":"Lombardi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B116","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1021\/acs.nanolett.2c00907","article-title":"Bioengineered platelets combining chemotherapy and immunotherapy for postsurgical melanoma treatment: internal core-loaded doxorubicin and external surface-anchored Anti-PD-L1 antibody backpacks","volume":"22","author":"Lu","year":"2022","journal-title":"Nano Lett."},{"key":"B117","doi-asserted-by":"publisher","first-page":"113546","DOI":"10.1016\/j.jconrel.2025.02.042","article-title":"Long-acting bioengineered platelets with internal doxorubicin loaded and external quercetin liposomes anchored for post-surgical tumor therapy","volume":"381","author":"Lu","year":"2025","journal-title":"J. Control. Release"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1200\/JCO.2014.55.9575","article-title":"Lessons from anti\u2013vascular endothelial growth factor and anti\u2013vascular endothelial growth factor receptor trials in patients with glioblastoma","volume":"33","author":"Lu-Emerson","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"eabd7614","DOI":"10.1126\/sciadv.abd7614","article-title":"Near-infrared light\u2013triggered platelet arsenal for combined photothermal-immunotherapy against cancer","volume":"7","author":"Lv","year":"2021","journal-title":"Sci. Adv."},{"key":"B120","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1083\/jcb.201304054","article-title":"The incredible journey: from megakaryocyte development to platelet formation","volume":"201","author":"Machlus","year":"2013","journal-title":"J. Cell Biol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"a020388","DOI":"10.1101\/cshperspect.a020388","article-title":"Astrocyte regulation of blood flow in the brain","volume":"7","author":"MacVicar","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJMoa2504650","article-title":"Low-dose aspirin for PI3K-Altered localized colorectal cancer","volume":"393","author":"Martling","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"25860","DOI":"10.18632\/oncotarget.25395","article-title":"Platelet activation parameters and platelet-leucocyte-conjugate formation in glioblastoma multiforme patients","volume":"9","author":"Marx","year":"2018","journal-title":"Oncotarget"},{"key":"B124","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1440-1789.2008.00963.x","article-title":"The terminal prostaglandin synthases mPGES\u20101, mPGES\u20102, and cPGES are all overexpressed in human gliomas","volume":"29","author":"Mattila","year":"2009","journal-title":"Neuropathology"},{"key":"B125","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1194\/jlr.D081414","article-title":"Analysis of HETEs in human whole blood by chiral UHPLC-ECAPCI\/HRMS","volume":"59","author":"Mazaleuskaya","year":"2018","journal-title":"J. Lipid Res."},{"key":"B126","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jconrel.2020.05.016","article-title":"Platelet membrane-cloaked paclitaxel-nanocrystals augment postoperative chemotherapeutical efficacy","volume":"324","author":"Mei","year":"2020","journal-title":"J. Control. Release"},{"key":"B127","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3390\/pharmaceutics15030953","article-title":"Clinically expired platelet concentrates as a source of extracellular vesicles for targeted anti-cancer drug delivery","volume":"15","author":"Meliciano","year":"2023","journal-title":"Pharmaceutics"},{"key":"B128","doi-asserted-by":"publisher","first-page":"113804","DOI":"10.1016\/j.ejmech.2021.113804","article-title":"Synthetically-tailored and nature-derived dual COX-2\/5-LOX inhibitors: structural aspects and SAR","volume":"225","author":"Meshram","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"B129","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s40478-020-00989-4","article-title":"Microglia depletion diminishes key elements of the leukotriene pathway in the brain of Alzheimer\u2019s disease mice","volume":"8","author":"Michael","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"B130","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ejmech.2019.01.067","article-title":"Role of PPAR receptor in different diseases and their ligands: physiological importance and clinical implications","volume":"166","author":"Mirza","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"B131","doi-asserted-by":"publisher","first-page":"a041354","DOI":"10.1101\/cshperspect.a041354","article-title":"Astrocyte regulation of cerebral blood flow in health and disease","volume":"16","author":"Mishra","year":"2024","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.3390\/cancers12071960","article-title":"Therapeutic strategies for overcoming immunotherapy resistance mediated by immunosuppressive factors of the glioblastoma microenvironment","volume":"12","author":"Miyazaki","year":"2020","journal-title":"Cancers"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3390\/molecules22071124","article-title":"Substituted caffeic and ferulic acid phenethyl esters: synthesis, leukotrienes biosynthesis inhibition, and cytotoxic activity","volume":"22","author":"Morin","year":"2017","journal-title":"Molecules"},{"key":"B134","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev.nutr.24.121803","article-title":"Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases","volume":"24","author":"Nakamura","year":"2004","journal-title":"Annu. Rev. Nutr."},{"key":"B135","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00281-012-0342-8","article-title":"Multifaceted roles of PGE2 in inflammation and cancer","volume":"35","author":"Nakanishi","year":"2013","journal-title":"Semin. Immunopathol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3171\/JNS\/2008\/108\/2\/0311","article-title":"Induction of prostaglandin E2 synthesis and microsomal prostaglandin E synthase\u20131 expression in murine microglia by glioma-derived soluble factors: laboratory investigation","volume":"108","author":"Nakano","year":"2008","journal-title":"J. Neurosurg."},{"key":"B137","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","article-title":"Drug delivery to the central nervous system","volume":"7","author":"Nance","year":"2021","journal-title":"Nat. Rev. Mater"},{"key":"B138","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11910-024-01338-x","article-title":"Strategies to improve drug delivery across the blood\u2013brain barrier for glioblastoma","volume":"24","author":"Narsinh","year":"2024","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B139","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/JCI200113455","article-title":"Genetic and pharmacological analysis of prostanoid receptor function","volume":"108","author":"Narumiya","year":"2001","journal-title":"J. Clin. Invest"},{"key":"B140","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1227\/01.NEU.0000195096.43258.94","article-title":"Increased expression of 5-lipoxygenase in high-grade astrocytomas","volume":"58","author":"Nathoo","year":"2006","journal-title":"Neurosurgery"},{"key":"B141","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev.bi.55.070186","article-title":"Arachidonic acid metabolism","volume":"55","author":"Needleman","year":"1986","journal-title":"Annu. Rev. Biochem."},{"key":"B142","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jconrel.2023.03.009","article-title":"Engineered EVs designed to target diseases of the CNS","volume":"356","author":"Nieland","year":"2023","journal-title":"J. Control Release Off. J. Control Release Soc."},{"key":"B143","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13045-022-01351-y","article-title":"Liquid biopsy: current technology and clinical applications","volume":"15","author":"Nikanjam","year":"2022","journal-title":"J. Hematol. OncolJ Hematol. Oncol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1182\/blood-2011-03-344408","article-title":"Blood platelets contain tumor-derived RNA biomarkers","volume":"118","author":"Nilsson","year":"2011","journal-title":"Blood"},{"key":"B145","doi-asserted-by":"publisher","first-page":"101505","DOI":"10.1016\/j.xcrp.2023.101505","article-title":"Platelet-derived exosomes hybrid liposomes facilitate uninterrupted singlet oxygen generation to enhance breast cancer immunotherapy","volume":"4","author":"Ning","year":"2023","journal-title":"Cell Rep. Phys. Sci."},{"key":"B146","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1038\/mt.2014.128","article-title":"Systemic administration of platelets incorporating inactivated sendai virus eradicates melanoma in mice","volume":"22","author":"Nishikawa","year":"2014","journal-title":"Mol. Ther."},{"key":"B147","doi-asserted-by":"publisher","first-page":"287","DOI":"10.20517\/cdr.2020.29","article-title":"Drug resistance in glioblastoma: are persisters the key to therapy?","volume":"3","author":"Oliver","year":"2020","journal-title":"Cancer Drug Resist"},{"key":"B148","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/09537104.2018.1453059","article-title":"The pro-inflammatory role of platelets in cancer","volume":"29","author":"Olsson","year":"2018","journal-title":"Platelets"},{"key":"B149","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1440-1789.2007.00828.x","article-title":"Cyclooxygenase\u20102 (cox\u20102) expression and angiogenesis in glioblastoma","volume":"28","author":"Onguru","year":"2008","journal-title":"Neuropathology"},{"key":"B150","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016\u20142020","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro-Oncol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"110629","DOI":"10.1016\/j.jbc.2025.110629","article-title":"Recent updates in Mammalian oxylipin biochemistry","volume":"301","author":"O\u2019Donnell","year":"2025","journal-title":"J. Biol. Chem."},{"key":"B152","doi-asserted-by":"publisher","first-page":"7172","DOI":"10.1038\/s41467-023-41766-w","article-title":"Failure to apply standard limit-of-detection or limit-of-quantitation criteria to specialized pro-resolving mediator analysis incorrectly characterizes their presence in biological samples","volume":"14","author":"O\u2019Donnell","year":"2023","journal-title":"Nat. Commun."},{"key":"B153","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2174\/187152806776383125","article-title":"Lipoxin and synthetic lipoxin analogs: an overview of Anti- inflammatory functions and new concepts in immunomodulation","volume":"5","author":"Parkinson","year":"2006","journal-title":"Inflamm. Allergy-Drug Targets"},{"key":"B154","first-page":"229","article-title":"20-Hydroxyeicosatetraenoic acid (20-HETE): bioactions, receptors, vascular function, cardiometabolic disease and beyond","volume-title":"Advances in Pharmacology","author":"Pascale","year":"2023"},{"key":"B155","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jacc.2016.05.083","article-title":"Aspirin and cancer","volume":"68","author":"Patrignani","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.bbalip.2014.09.016","article-title":"Cyclooxygenase inhibitors: from pharmacology to clinical read-outs","volume":"1851","author":"Patrignani","year":"2015","journal-title":"Biochim. Biophys. Acta BBA - Mol. Cell Biol. Lipids"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1172\/JCI110576","article-title":"Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects","volume":"69","author":"Patrignani","year":"1982","journal-title":"J. Clin. Invest"},{"key":"B158","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0022-3565(25)24061-7","article-title":"Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases","volume":"271","author":"Patrignani","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B159","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1111\/jth.12637","article-title":"Reappraisal of the clinical pharmacology of low\u2010dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action","volume":"12","author":"Patrignani","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"B160","doi-asserted-by":"publisher","first-page":"106388","DOI":"10.1016\/j.ebiom.2026.106388","article-title":"Precision oncology in adjuvant aspirin therapy for colorectal cancer: emerging genetic markers and persistent uncertainties","volume":"130","author":"Patrignani","year":"2026","journal-title":"eBioMedicine"},{"key":"B161","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1124\/jpet.122.001631","article-title":"Cyclooxygenase inhibitors and cancer: the missing pieces","volume":"386","author":"Patrono","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B162","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0049-3848(80)90066-3","article-title":"Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects","volume":"17","author":"Patrono","year":"1980","journal-title":"Thromb. Res."},{"key":"B163","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1172\/JCI13418","article-title":"Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs","volume":"108","author":"Patrono","year":"2001","journal-title":"J. Clin. Invest"},{"key":"B164","doi-asserted-by":"publisher","first-page":"100109","DOI":"10.1016\/j.pharmr.2025.100109","article-title":"Platelet activation, aspirin, and cancer: from basic science to clinical trials","volume":"78","author":"Patrono","year":"2026","journal-title":"Pharmacol. Rev."},{"key":"B165","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10571-017-0507-z","article-title":"Cysteinyl leukotriene receptor antagonists inhibit migration, invasion, and expression of MMP-2\/9 in human glioblastoma","volume":"38","author":"Piromkraipak","year":"2018","journal-title":"Cell Mol. Neurobiol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.bbalip.2014.10.008","article-title":"Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid","volume":"1851","author":"Powell","year":"2015","journal-title":"Biochim. Biophys. Acta BBA"},{"key":"B167","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1161\/ATVBAHA.120.314644","article-title":"Platelet extracellular vesicles: beyond the blood","volume":"41","author":"Puhm","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.drudis.2016.09.017","article-title":"Cyclooxygenase-2 in glioblastoma multiforme","volume":"22","author":"Qiu","year":"2017","journal-title":"Drug Discov. Today"},{"key":"B169","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1111\/bph.16148","article-title":"Complementary roles of EP2 and EP4 receptors in malignant glioma","volume":"180","author":"Qiu","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/anie.201709457","article-title":"Platelet\u2010facilitated photothermal therapy of head and neck squamous cell carcinoma","volume":"57","author":"Rao","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"B171","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3390\/ph17080973","article-title":"A review of therapeutic agents given by convection-enhanced delivery for adult glioblastoma","volume":"17","author":"Rolfe","year":"2024","journal-title":"Pharmaceuticals"},{"key":"B173","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"B174","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1126\/science.6301011","article-title":"Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation","volume":"220","author":"Samuelsson","year":"1983","journal-title":"Science"},{"key":"B175","doi-asserted-by":"publisher","first-page":"e00188","DOI":"10.1002\/prp2.188","article-title":"Microparticle of drug and nanoparticle: a biosynthetic route","volume":"3","author":"Sarkar","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"B176","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1007\/s11095-013-1097-1","article-title":"Drug delivery using platelet cancer cell interaction","volume":"30","author":"Sarkar","year":"2013","journal-title":"Pharm. Res."},{"key":"B177","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/neuonc\/nox175","article-title":"Is the blood\u2013brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data","volume":"20","author":"Sarkaria","year":"2017","journal-title":"Neuro-Oncol"},{"key":"B178","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.canlet.2009.10.008","article-title":"MK591, a leukotriene biosynthesis inhibitor, induces apoptosis in prostate cancer cells: synergistic action with LY294002, an inhibitor of phosphatidylinositol 3\u2019-kinase","volume":"291","author":"Sarveswaran","year":"2010","journal-title":"Cancer Lett."},{"key":"B179","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/intimm\/dxz044","article-title":"The leukotriene receptors as therapeutic targets of inflammatory diseases","volume":"31","author":"Sasaki","year":"2019","journal-title":"Int. Immunol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.bcp.2013.04.015","article-title":"Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin","volume":"86","author":"Schaible","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"838782","DOI":"10.3389\/fphar.2022.838782","article-title":"Formation, signaling and occurrence of specialized pro-resolving lipid mediators\u2014what is the evidence so far?","volume":"13","author":"Schebb","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1182\/blood-2013-12-544445","article-title":"Platelets induce apoptosis via membrane-bound FasL","volume":"126","author":"Schleicher","year":"2015","journal-title":"Blood"},{"key":"B183","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1158\/1078-0432.CCR-17-0895","article-title":"Low-dose cyclophosphamide induces antitumor T-Cell responses, which associate with survival in metastatic colorectal cancer","volume":"23","author":"Scurr","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"B184","doi-asserted-by":"publisher","first-page":"106389","DOI":"10.1016\/j.ebiom.2026.106389","article-title":"Adjuvant aspirin for colorectal cancer with PIK3CA-mutated and COX-2 overexpressed tumours: the ASCOLT translational research study and meta-analysis","volume":"130","author":"Segelov","year":"2026","journal-title":"eBioMedicine"},{"key":"B185","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00262-026-04372-5","article-title":"Targeting the COX-2\/PGE2 axis to enhance NK and T cell immunotherapy in brain tumors","volume":"75","author":"Shen","year":"2026","journal-title":"Cancer Immunol. Immunother."},{"key":"B186","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"B187","first-page":"4375","article-title":"Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations","volume":"61","author":"Shono","year":"2001","journal-title":"Cancer Res."},{"key":"B188","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1124\/dmd.108.023416","article-title":"Mechanism of CYP2C9 inhibition by flavones and flavonols","volume":"37","author":"Si","year":"2009","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"B189","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1124\/pr.56.3.3","article-title":"Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition","volume":"56","author":"Simmons","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"B190","doi-asserted-by":"publisher","first-page":"vdac172","DOI":"10.1093\/noajnl\/vdac172","article-title":"Glioma stem cells activate platelets by plasma-independent thrombin production to promote glioblastoma tumorigenesis","volume":"4","author":"Sloan","year":"2022","journal-title":"Neuro-Oncol Adv."},{"key":"B191","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00432-005-0020-5","article-title":"Expression of cyclooxygenase-2 and epidermal growth factor receptor in primary and recurrent glioblastoma multiforme","volume":"131","author":"Sminia","year":"2005","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"B193","doi-asserted-by":"publisher","first-page":"S423","DOI":"10.1194\/jlr.R800094-JLR200","article-title":"Prostanoids in health and disease","volume":"50","author":"Smyth","year":"2009","journal-title":"J. Lipid Res."},{"key":"B194","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3389\/fphar.2019.00719","article-title":"Regulation and functions of 15-Lipoxygenases in human macrophages","volume":"10","author":"Snodgrass","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B195","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/neuonc\/noac004","article-title":"Liquid biopsy in gliomas: a RANO review and proposals for clinical applications","volume":"24","author":"Soffietti","year":"2022","journal-title":"Neuro-Oncol"},{"key":"B196","doi-asserted-by":"publisher","first-page":"100101","DOI":"10.1016\/j.xcrm.2020.100101","article-title":"Tumor-educated platelet RNA for the detection and (pseudo)progression monitoring of glioblastoma","volume":"1","author":"Sol","year":"2020","journal-title":"Cell Rep. Med."},{"key":"B197","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jddst.2019.03.009","article-title":"Platelet microparticles: an effective delivery system for anti-viral drugs","volume":"51","author":"Soleymani","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12920-024-01991-8","article-title":"Integrated bioinformatics analysis and experimental validation reveal the relationship between ALOX5AP and the prognosis and immune microenvironment in glioma","volume":"17","author":"Song","year":"2024","journal-title":"BMC Med. Genomics"},{"key":"B199","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2147\/OTT.S31586","article-title":"Targeting 20-HETE producing enzymes in cancer \u2013 rationale, pharmacology, and clinical potential","volume":"243","author":"Sorokin","year":"2013","journal-title":"OncoTargets Ther."},{"key":"B200","doi-asserted-by":"publisher","first-page":"8395","DOI":"10.3390\/ijms21218395","article-title":"Influence of lipoxygenase inhibition on glioblastoma cell biology","volume":"21","author":"Souza","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B201","doi-asserted-by":"publisher","first-page":"C996","DOI":"10.1152\/ajpcell.00402.2006","article-title":"Action of epoxyeicosatrienoic acids on cellular function","volume":"292","author":"Spector","year":"2007","journal-title":"Am. J. Physiol-Cell Physiol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1388-1981(00)00077-9","article-title":"Metabolism of highly unsaturated n-3 and n-6 fatty acids","volume":"1486","author":"Sprecher","year":"2000","journal-title":"Biochim. Biophys. Acta BBA - Mol. Cell Biol. Lipids"},{"key":"B203","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/biomedicines7030069","article-title":"Temozolomide and other alkylating agents in glioblastoma therapy","volume":"7","author":"Strobel","year":"2019","journal-title":"Biomedicines"},{"key":"B204","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/NEUROSURGERY\/57.1.N7A","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"B205","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1194\/jlr.M053058","article-title":"12\/15-Lipoxygenase metabolites of arachidonic acid activate PPAR\u03b3: a possible neuroprotective effect in ischemic brain","volume":"56","author":"Sun","year":"2015","journal-title":"J. Lipid Res."},{"key":"B206","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fphar.2014.00239","article-title":"Inside epoxyeicosatrienoic acids and cardiovascular disease","volume":"5","author":"Tacconelli","year":"2014","journal-title":"Front. Pharmacol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1742-2094-8-32","article-title":"Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma","volume":"8","author":"Tafani","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"B208","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1002\/ijc.33915","article-title":"Treatment of hepatocellular carcinoma with autologous platelets encapsulating sorafenib or lenvatinib: a novel therapy exploiting tumor\u2010platelet interactions","volume":"150","author":"Tanaka","year":"2022","journal-title":"Int. J. Cancer"},{"key":"B209","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0090-6980(93)90051-8","article-title":"12(S)-HETE-induced microvascular endothelial cell retraction results from PKC-Dependent rearrangement of cytoskeletal elements and \u03b1V\u03b23 integrins","volume":"45","author":"Tang","year":"1993","journal-title":"Prostaglandins"},{"key":"B210","doi-asserted-by":"publisher","first-page":"eaba6137","DOI":"10.1126\/scirobotics.aba6137","article-title":"Enzyme-powered janus platelet cell robots for active and targeted drug delivery","volume":"5","author":"Tang","year":"2020","journal-title":"Sci. Robot."},{"key":"B211","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.1002\/cam4.4066","article-title":"ALOX5-5-HETE promotes gastric cancer growth and alleviates chemotherapy toxicity via MEK\/ERK activation","volume":"10","author":"Tang","year":"2021","journal-title":"Cancer Med."},{"key":"B212","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41698-023-00431-7","article-title":"Tumor-associated macrophage-related strategies for glioma immunotherapy","volume":"7","author":"Tang","year":"2023","journal-title":"Npj Precis. Oncol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/md19020118","article-title":"\u03b1-Conotoxins and \u03b1-Cobratoxin promote, while lipoxygenase and cyclooxygenase inhibitors suppress the proliferation of glioma C6 cells","volume":"19","author":"Terpinskaya","year":"2021","journal-title":"Mar. Drugs"},{"key":"B214","doi-asserted-by":"publisher","first-page":"e2502640122","DOI":"10.1073\/pnas.2502640122","article-title":"12\/15-lipoxygenase orchestrates murine wound healing via PPAR\u03b3-activating oxylipins acting holistically to dampen inflammation","volume":"122","author":"Thomas","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B215","doi-asserted-by":"publisher","first-page":"8501","DOI":"10.1074\/jbc.275.12.8501","article-title":"Different catalytically competent arrangements of arachidonic acid within the cyclooxygenase active site of prostaglandin endoperoxide H Synthase-1 lead to the formation of different oxygenated products","volume":"275","author":"Thuresson","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B216","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/CEJ.0b013e328339648c","article-title":"Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer","volume":"19","author":"Tian","year":"2010","journal-title":"Eur. J. Cancer Prev. Off. J. Eur. Cancer Prev. Organ"},{"key":"B217","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10571-025-01543-3","article-title":"The effects and mechanisms of n-3 and n-6 polyunsaturated fatty acids in the central nervous system","volume":"45","author":"Tian","year":"2025","journal-title":"Cell Mol. Neurobiol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12929-022-00804-3","article-title":"Reprogramming of arachidonate metabolism confers temozolomide resistance to glioblastoma through enhancing mitochondrial activity in fatty acid oxidation","volume":"29","author":"Tsai","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"B219","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B220","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bcpt.13402","article-title":"The potential of leukotriene receptor antagonists as anticancer drugs","volume":"126","author":"Vivithanaporn","year":"2020","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"B222","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1172\/JCI61453","article-title":"Epoxyeicosatrienoic acids: a double-edged sword in cardiovascular diseases and cancer","volume":"122","author":"Wang","year":"2012","journal-title":"J. Clin. Invest"},{"key":"B223","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/S0022-2275(20)42114-5","article-title":"Localization of 12-hydroxyeicosatetraenoic acid in endothelial cells","volume":"31","author":"Wang","year":"1990","journal-title":"J. Lipid Res."},{"key":"B224","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s12015-010-9175-9","article-title":"An inhibitor of arachidonate 5-Lipoxygenase, nordy, induces differentiation and inhibits self-renewal of glioma stem-like cells","volume":"7","author":"Wang","year":"2011","journal-title":"Stem Cell Rev. Rep."},{"key":"B225","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11060-015-1919-6","article-title":"Co-expression of COX-2 and 5-LO in primary glioblastoma is associated with poor prognosis","volume":"125","author":"Wang","year":"2015","journal-title":"J. Neurooncol"},{"key":"B226","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/s0254-6272(16)30071-1","article-title":"Breast cancer stem-like cells can promote metastasis by activating platelets and down-regulating antitumor activity of natural killer cells","volume":"36","author":"Wang","year":"2016","journal-title":"J. Tradit. Chin. Med. Chung Tsa Chih Ying Wen Pan"},{"key":"B227","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.canlet.2017.05.030","article-title":"Inhibition of CYP4A by a novel flavonoid FLA-16 prolongs survival and normalizes tumor vasculature in glioma","volume":"402","author":"Wang","year":"","journal-title":"Cancer Lett."},{"key":"B228","doi-asserted-by":"publisher","first-page":"0011","DOI":"10.1038\/s41551-016-0011","article-title":"In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy","volume":"1","author":"Wang","year":"","journal-title":"Nat. Biomed. Eng."},{"key":"B229","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12951-019-0494-y","article-title":"Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery","volume":"17","author":"Wang","year":"2019","journal-title":"J. Nanobiotechnology"},{"key":"B230","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"B231","doi-asserted-by":"publisher","first-page":"18327","DOI":"10.1021\/acsnano.1c07587","article-title":"AMicrofluidics-Based scalable approach to GenerateExtracellular vesicles with enhanced therapeutic MicroRNA loadingfor intranasal delivery to mouse glioblastomas","volume":"15","author":"Wang","year":"2021","journal-title":"ACS Nano"},{"key":"B232","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1039\/D2CS00142J","article-title":"Chemically engineering cells for precision medicine","volume":"52","author":"Wang","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"B233","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/cells15030309","article-title":"Decoding glioblastoma through liquid biopsy: molecular insights and clinical prospects","volume":"15","author":"Wasiak","year":"2026","journal-title":"Cells"},{"key":"B234","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/09537100400007390","article-title":"Platelets are covercytes, not phagocytes: uptake of bacteria involves channels of the open canalicular system","volume":"16","author":"White","year":"2005","journal-title":"Platelets"},{"key":"B235","doi-asserted-by":"publisher","first-page":"35287","DOI":"10.18632\/oncotarget.26228","article-title":"T-cell exhaustion in glioblastoma","volume":"9","author":"Woroniecka","year":"2018","journal-title":"Oncotarget"},{"key":"B236","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.2147\/IJN.S200284","article-title":"Cell membrane camouflaged nanoparticles: a new biomimetic platform for cancer photothermal therapy","volume":"14","author":"Wu","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"B237","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12929-020-00633-2","article-title":"Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop","volume":"27","author":"Wu","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"B238","doi-asserted-by":"publisher","first-page":"910543","DOI":"10.3389\/fnmol.2022.910543","article-title":"Research progress on the regulation mechanism of key signal pathways affecting the prognosis of glioma","volume":"15","author":"Wu","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"B239","doi-asserted-by":"publisher","first-page":"2237134","DOI":"10.1080\/09537104.2023.2237134","article-title":"Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization","volume":"34","author":"Wu","year":"2023","journal-title":"Platelets"},{"key":"B240","doi-asserted-by":"publisher","first-page":"6121","DOI":"10.1158\/0008-5472","article-title":"EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1\/Sp3 transcription factors in human gliomas","volume":"67","author":"Xu","year":"2007","journal-title":"Cancer Res."},{"key":"B241","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1124\/jpet.108.138776","article-title":"MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazole-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation","volume":"326","author":"Xu","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B242","doi-asserted-by":"publisher","first-page":"42632","DOI":"10.1038\/srep42632","article-title":"Doxorubicin-loaded platelets as a smart drug delivery system: an improved therapy for lymphoma","volume":"7","author":"Xu","year":"2017","journal-title":"Sci. Rep."},{"key":"B243","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1182\/blood-2017-05-743187","article-title":"Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents","volume":"131","author":"Xu","year":"2018","journal-title":"Blood"},{"key":"B244","doi-asserted-by":"publisher","first-page":"1516836","DOI":"10.3389\/fphar.2025.1516836","article-title":"Zileuton protects against arachidonic acid\/5-lipoxygenase\/leukotriene axis-mediated neuroinflammation in experimental traumatic brain injury","volume":"16","author":"Xu","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B245","doi-asserted-by":"publisher","first-page":"4754","DOI":"10.1007\/s12035-015-9355-3","article-title":"Pathophysiological roles of cyclooxygenases and prostaglandins in the central nervous system","volume":"53","author":"Yagami","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"B246","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/0896-6273(93)90192-T","article-title":"Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids","volume":"11","author":"Yamagata","year":"1993","journal-title":"Neuron"},{"key":"B247","doi-asserted-by":"publisher","first-page":"2109517","DOI":"10.1002\/adma.202109517","article-title":"Platelet pharmacytes for the hierarchical amplification of antitumor immunity in response to self\u2010generated immune signals","volume":"34","author":"Yan","year":"2022","journal-title":"Adv. Mater"},{"key":"B248","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41389-021-00304-3","article-title":"miR-18a promotes glioblastoma development by down-regulating ALOXE3-mediated ferroptotic and anti-migration activities","volume":"10","author":"Yang","year":"2021","journal-title":"Oncogenesis"},{"key":"B249","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1016\/j.matt.2023.04.026","article-title":"T cell-mimicking platelet-drug conjugates","volume":"6","author":"Yang","year":"2023","journal-title":"Matter"},{"key":"B250","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s41586-025-08626-7","article-title":"Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity","volume":"640","author":"Yang","year":"2025","journal-title":"Nature"},{"key":"B251","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/s0006-8993(99)01389-x","article-title":"Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs","volume":"830","author":"Yasojima","year":"1999","journal-title":"Brain Res."},{"key":"B252","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1021\/acsbiomaterials.5c00473","article-title":"Platelet extracellular vesicles as natural delivery vehicles for mitochondrial dysfunction therapy?","volume":"11","author":"Yeh","year":"2025","journal-title":"ACS Biomater. Sci. Eng."},{"key":"B253","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1097\/00005072-199911000-00003","article-title":"Cyclooxygenase-1 in human alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons","volume":"58","author":"Yermakova","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B254","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1172\/JCI97946","article-title":"Leukotriene receptors as potential therapeutic targets","volume":"128","author":"Yokomizo","year":"2018","journal-title":"J. Clin. Invest"},{"key":"B255","doi-asserted-by":"publisher","first-page":"7283","DOI":"10.1158\/0008-5472.CAN-05-0633","article-title":"15(S)-Hydroxyeicosatetraenoic acid induces angiogenesis via activation of PI3K-Akt-mTOR-S6K1 signaling","volume":"65","author":"Zhang","year":"2005","journal-title":"Cancer Res."},{"key":"B256","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ejphar.2018.06.010","article-title":"Conflicting roles of 20-HETE in hypertension and renal end organ damage","volume":"833","author":"Zhang","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"B257","doi-asserted-by":"publisher","first-page":"5716","DOI":"10.1021\/acs.nanolett.8b02321","article-title":"Engineering PD-1-Presenting platelets for cancer immunotherapy","volume":"18","author":"Zhang","year":"2018","journal-title":"Nano Lett."},{"key":"B258","doi-asserted-by":"publisher","first-page":"6359","DOI":"10.1021\/acsnano.2c00453","article-title":"A platelet intelligent vehicle with navigation for cancer photothermal-chemotherapy","volume":"16","author":"Zhang","year":"2022","journal-title":"ACS Nano"},{"key":"B259","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1039\/D3BM00326D","article-title":"Glucose-decorated engineering platelets for active and precise tumor-targeted drug delivery","volume":"11","author":"Zhao","year":"2023","journal-title":"Biomater. Sci."},{"key":"B260","doi-asserted-by":"publisher","first-page":"e202403541","DOI":"10.1002\/anie.202403541","article-title":"Platelet\u2010drug conjugates engineered via one step fusion approach for metastatic and postoperative cancer treatment","volume":"63","author":"Zhao","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"B261","doi-asserted-by":"publisher","first-page":"1801899","DOI":"10.1002\/advs.201801899","article-title":"Embryonic stem cells-derived exosomes endowed with targeting properties as chemotherapeutics delivery vehicles for glioblastoma therapy","volume":"6","author":"Zhu","year":"2019","journal-title":"Adv. Sci."},{"key":"B262","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11060-024-04795-z","article-title":"Focused ultrasound-mediated enhancement of blood\u2013brain barrier permeability for brain tumor treatment: a systematic review of clinical trials","volume":"170","author":"Zhu","year":"2024","journal-title":"J. Neurooncol"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1956969\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:41:22Z","timestamp":1790833282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1956969\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":262,"alternative-id":["10.3389\/fphar.2026.1956969"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1956969","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"1956969"}}